ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 31 - 45 of 5996 products
Hasten Biopharma In-licenses Pan-Asia Distribution Rights for 14 Products
$5.00
Available
Samsung Bio Signs $1 Billion Manufacturing Agreement with US Pharma
$5.00
Available
HiRO Adds New Jersey’s DeltaMed Solutions to its Portfolio of CROs
$5.00
Available
Eisai Plans to Speed Development of ADC After BMS Returns Rights
$5.00
Available
CASI Pharma’s CEO Offers $40 Million to Take Company Private
$5.00
Available
Innovent Says GLP-1R/GCGR Reduces Liver Fat and Improves Metabolic Health
$5.00
Available
Novo Nordisk’s Wegovy Approved in China, But Patent Expires in Two Years
$5.00
Available
Simcere Zaiming Approved to Launch Novel EGFR for Metastatic Colorectal Cancer
$5.00
Available
Gan & Lee Says GLP-1 Candidate Offers Strong Weight Loss in Early Trial
$5.00
Available
AprilBio Out-Licenses Rights for IL-18 Candidate to California’s Evommune
$5.00
Available
Fosun Pharma Sells 5% Stake in India’s Gland Pharma for $172 Million
$5.00
Available
Rapafusyn Pharma Raises $28 Million for Molecular Glues from China Investors
$5.00
Available
MabCare Out-Licenses PTK7 ADC to Day One Biopharma in $1.2 Billion Deal
$5.00
Available
Ronovo Surgical Raises $44 Million to Commercialize Carina™ Surgical Robotic System
$5.00
Available
YolTech Out-Licenses China Rights for CRISPR/Cas Editor to KACTUS
$5.00
Available